To this end, we retrieved and analyzed data from the CPTAC-BRCA cohort21, which contains paired gene expression and phospho-proteomic data from 120 treatment-naïve breast cancer patients with known ER−status, i.e., ER− (n = 39) and ER+ (n = 81) disease. The gene discussed is ESR1; the disease is breast carcinoma.